Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

COPAN DIAGNOSTICS

COPAN (which stands for COllection and Preservation for ANalysis) is a global market leader in sample collection and ... read more Featured Products: More products

Download Mobile App





Copan Showcases Fully Automated Solutions for Antibiotic Susceptibility Testing at ECCMID 2022

By LabMedica International staff writers
Posted on 25 Apr 2022

COPAN Diagnostics (Murrieta, CA, USA) showcased its range of fully automated solutions for identification and antimicrobial susceptibility testing (AST) in clinical microbiology at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022). More...

COPAN demonstrated the FDA-cleared Colibri, a fully automated specimen workup instrument designed to prepare MALDI-TOF ID targets and create bacterial suspensions for AST. Colibri is an in vitro diagnostic device for use with the bioMérieux VITEK MS or Bruker MALDI Biotyper CA mass spectrometry systems. It automatically picks isolated colonies for further workup and investigations. Colibri can also seed colonies into various size tubes or bottles to prepare McFarland suspensions for AST, verifying opacity of suspensions using the onboard nephelometer. The system applies barcode labels to tubes and prepares purity check plates from these suspensions.

Colibri is paired with COPAN’s artificial intelligence (AI) software, PhenoMATRIX, to offer clinical microbiology laboratories cutting-edge, intelligence driven solutions for specimen workup to help streamline workflow and address the most challenging demands in the laboratory. PhenoMATRIX TAG colony selection software automatically chooses isolated colonies on plated media for picking. By grouping negative cultures, which represent the majority of cultures screened, Microbiologists can quickly review up to 40 plates at a time and batch release negative results quickly. Eliminating the need to review each plate manually, saves precious time and allows technicians to focus on complex cultures which require their unique expertise, and to consult with physicians to provide better patient care.

COPAN also exhibited its UniVerse fully automated instrument for molecular specimen preparation. UniVerse revolutionizes up front sample processing for molecular diagnostics automatically managing accessioning, labeling, vortexing, and aliquoting into assay tubes and 96-well plates. UniVerse is fully LIS interfaced, it increases laboratory throughput with complete traceability, reliability and accuracy. It increases productivity while decreasing operational cost and allows valuable human resources to be re-deployed to higher level tasks.

Related Links:
COPAN Diagnostics 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.